← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 16, 2019Last known activity
Sep 2, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT07039617CollaboratorN/ASep 2, 2025
- NCT04233034CollaboratorPhase 3Apr 30, 2020
- NCT04201496CollaboratorPhase 1Dec 16, 2019
Details
- Last known activity
- Sep 2, 2025